Literature DB >> 31000212

Coexistence of variants in TBK1 and in other ALS-related genes elucidates an oligogenic model of pathogenesis in sporadic ALS.

Serena Lattante1, Paolo Niccolò Doronzio1, Giuseppe Marangi1, Amelia Conte2, Giulia Bisogni2, Daniela Bernardo2, Tommaso Russo3, Dante Lamberti4, Sara Patrizi1, Francesco Paolo Apollo5, Christian Lunetta6, Stefania Scarlino7, Laura Pozzi7, Marcella Zollino1, Nilo Riva7, Mario Sabatelli8.   

Abstract

Variants in tank-binding kinase 1 (TBK1) are responsible for a significant proportion of amyotrophic lateral sclerosis (ALS) cases. In the present study, we analyzed variants in TBK1 extracted by targeted sequencing of 32 genes in a group of 406 Italian patients with ALS. We identified 7 different TBK1 variants in 7 sporadic cases, resulting in a frequency of 1.7%. Three patients had missense variants (p.R357Q, p.R358H, and p.R724C), one patient had a small deletion (p.E618del), and 3 had truncating variants (p.Y482*, p.R229*, and p.N681*). Notably, we found that 4 patients had an additional variant in ALS-related genes: 2 in OPTN and 2 in the 3'UTR region of FUS. By studying an independent group of 7 TBK1-mutated patients previously reported, we found another variant in the 3'UTR region of FUS in one patient. The presence of a second variant in TBK1 variant carriers is an interesting finding that needs to be investigated in larger cohorts of patients. These findings suggest that TBK1 belongs to the category of genes conferring a significantly increased risk but not sufficient to cause disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; FUS; OPTN; Oligogenicity; TBK1

Year:  2019        PMID: 31000212     DOI: 10.1016/j.neurobiolaging.2019.03.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

Review 1.  A novel variant in DYNC1H1 could contribute to human amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Authors:  Alexios-Fotios A Mentis; Dimitrios Vlachakis; Eleni Papakonstantinou; Ioannis Zaganas; George P Patrinos; George P Chrousos; Efthimios Dardiotis
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24

2.  High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines.

Authors:  Serena Lattante; Giuseppe Marangi; Paolo Niccolò Doronzio; Amelia Conte; Giulia Bisogni; Marcella Zollino; Mario Sabatelli
Journal:  Genes (Basel)       Date:  2020-09-24       Impact factor: 4.096

3.  The ALS-Associated FUS (P525L) Variant Does Not Directly Interfere with Microtubule-Dependent Kinesin-1 Motility.

Authors:  Anne Seifert; Hauke Drechsler; Julia Japtok; Till Korten; Stefan Diez; Andreas Hermann
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

4.  FUS mutations dominate TBK1 mutations in FUS/TBK1 double-mutant ALS/FTD pedigrees.

Authors:  David Brenner; Kathrin Müller; Serena Lattante; Rüstem Yilmaz; Antje Knehr; Axel Freischmidt; Albert C Ludolph; Peter M Andersen; Jochen H Weishaupt
Journal:  Neurogenetics       Date:  2021-09-13       Impact factor: 2.660

5.  Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients.

Authors:  A Joseph Bloom; Xianrong Mao; Amy Strickland; Yo Sasaki; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Mol Neurodegener       Date:  2022-01-06       Impact factor: 14.195

Review 6.  Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.

Authors:  Ramya Ranganathan; Shaila Haque; Kayesha Coley; Stephanie Shepheard; Johnathan Cooper-Knock; Janine Kirby
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

Review 7.  A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis.

Authors:  Georgios Pampalakis; Georgios Angelis; Eleni Zingkou; Kostas Vekrellis; Georgia Sotiropoulou
Journal:  Clin Transl Med       Date:  2022-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.